Top Gold Stocks To Buy Right Now

A rather unusual thing has just happened with Cliffs Natural Resources (NYSE:CLF). The company issued a press release which stated that Barron’s and Axiom Capital Management issued materially misleading statements regarding Cliffs’ CEO share purchases. Cliffs stated that it believed that the materially misleading statements were an intentional attempt to manipulate Cliffs’ share price to support the bearish position of Axiom and that the company had instructed its outside legal counsel to pursue appropriate legal action against all parties involved.

I am not a lawyer and I cannot comment on the legal side of this story. However, I have a strong view regarding another comment that Axiom’s Gordon Johnson, who is notoriously bearish on steel and iron ore, has made regarding Cliffs’ stock. According to Mr. Johnson, the recent purchase of 200,000 Cliffs shares by Cliffs’ CEO Lourenco Goncalves is bearish because Goncalves’ track record in purchasing Cliffs’ shares is poor.

I find it very strange that an analyst decides to share his view on a CEO market timing ability. Mr. Johnson’s logic is the same as, for example, when one says: “Goldman Sachs has just issued a buy rating on XYZ, so XYZ is a sell”. This is suitable for a private conversation but cannot be used for public discourse by an analyst of an investment firm. Purchases by members of the management team are not necessarily a bullish factor for the stock, however, I cannot find a single reason why management’s purchase of stock could be fundamentally bearish.

Top Gold Stocks To Buy Right Now: Comcast Corporation(CCV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CounterPath Co. (NASDAQ:CPAH) (TSE:CCV) has been given a consensus broker rating score of 2.00 (Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports.

Top Gold Stocks To Buy Right Now: Boston Private Financial Holdings, Inc.(BPFH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Boston Private Financial Hldg Inc (NASDAQ:BPFH) – Equities research analysts at SunTrust Banks cut their Q2 2018 earnings estimates for Boston Private Financial in a report released on Sunday, May 20th. SunTrust Banks analyst M. Young now expects that the bank will post earnings per share of $0.10 for the quarter, down from their previous forecast of $0.20.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Boston Private Financial (BPFH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Gold Stocks To Buy Right Now: CHS Inc(CHSCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about CHS Inc Preferred Shares Class B (NASDAQ:CHSCO) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CHS Inc Preferred Shares Class B earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.8637910025833 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top Gold Stocks To Buy Right Now: Innophos Holdings, Inc.(IPHS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    TheStreet upgraded shares of Innophos (NASDAQ:IPHS) from a c+ rating to a b rating in a research note published on Wednesday.

    Several other analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of Innophos from a hold rating to a sell rating in a report on Tuesday, February 27th. BidaskClub downgraded shares of Innophos from a sell rating to a strong sell rating in a report on Tuesday, February 27th.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Innophos (IPHS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BidaskClub upgraded shares of Innophos (NASDAQ:IPHS) from a strong sell rating to a sell rating in a research report report published on Friday morning.

Top Gold Stocks To Buy Right Now: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

Top Gold Stocks To Buy Right Now: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By ]

    Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Stephan Byrd]

    State Board of Administration of Florida Retirement System trimmed its stake in shares of Nucor (NYSE:NUE) by 5.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 441,516 shares of the basic materials company’s stock after selling 23,506 shares during the period. State Board of Administration of Florida Retirement System owned about 0.14% of Nucor worth $26,972,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nucor (NUE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *